Interests Register Renal and Ureteric Stones Advisory ...
12
Interests Register Renal Stones guideline committee 1 of 12 Interests Register Renal and Ureteric Stones Advisory Committee Publication Date: 12/12/2018 Name Role with NICE Type of interest Description of interest Relevant dates Comments Interest arose Interest declared Interest ceased Robert Calvert Committee Member Indirect Financial Support by company EDAP TMS to attend the European Association of Urology Annual Meeting in London in March 2017). Registration fees and usual expenses paid by commercial company to employer for attendance. Gave educational talk on lithotripsy machines for which no payment received. March 2017 on application Specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration. Direct Financial Private Practice at Spire Liverpool Hospital Director of Liverpool Urology Ltd. Urological treatments including stone management on application Specific interest. No action other than process of open declaration. Private practice in this area is a small proportion of the individual’s overall practice and mirrors their NHS work. Based on the need for the committee member’s expertise and a view that the potential for gain is minimal, in this instance NICE has confirmed
Transcript of Interests Register Renal and Ureteric Stones Advisory ...
Interests Register Renal Stones guideline committee 1 of 12
Interests Register
Renal and Ureteric Stones Advisory Committee Publication Date: 12/12/2018
Name Role with NICE
Type of interest Description of interest
Relevant dates Comments Interest arose
Interest declared
Interest ceased
Robert Calvert Committee Member Indirect
Financial
Support by company EDAP TMS to attend the European Association of Urology Annual Meeting in London in March 2017). Registration fees and usual expenses paid by commercial company to employer for attendance. Gave educational talk on lithotripsy machines for which no payment received.
March 2017
on application
Specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Direct
Financial
Private Practice at Spire Liverpool Hospital
Director of Liverpool Urology Ltd. Urological treatments including stone management
on application
Specific interest. No action other than process of open declaration. Private practice in this area is a small proportion of the individual’s overall practice and mirrors their NHS work. Based on the need for the committee member’s expertise and a view that the potential for gain is minimal, in this instance NICE has confirmed
Interests Register Renal Stones guideline committee 2 of 12
that the individual can continue to participate fully.
Indirect Financial
Course director for BAUS Residential Operative Endourology, Industry sponsorship from Strong and Boston to subsidize delegate fees (not received directly).
Oct 2017
1/9/17 Specific interest. No action other than process of open declaration.
Direct Financial
Invited speaker Chilean Urological Congress. They are providing transport and accommodation.
Nov 2017
1/9/17 Specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Direct Financial
Invited speaker RSM, They are providing travel.
Oct 2017
1/9/17 Specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Direct Financial
Invited speaker BAUS Endourology Annual Meeting, Accommodation paid.
Sept 2017
1/9/17 Specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Direct
Non-financial
Abstract reviewer for European Urology annual meeting 2018. Kidney stones: medical research
13/11/17 Specific interest. No action other than process of open declaration.
Direct financial Invited speaker at Chilean Urological Society Annual Meeting . No payment received. Only travel and
Nov 2017
15/1/18 Specific interest. Reasonable travel and subsistence expenses only.
Interests Register Renal Stones guideline committee 3 of 12
accommodation expenses covered.
No action other than process of open declaration.
Direct Non-financial
Abstract reviewer: British Association of Urological Surgeons Limited annual meeting,
Jan 2018
12/4/18 Non-specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Direct Non-financial
Senior author. Case report: Ureteric Pyogenic granulomas: A peculiar case of ureteric obstruction. 2018
12/4/18 Non-specific interest. No action other than process of open declaration.
Indirect Financial
Organiser, abstract reviewer and chair: Mersey regional Urology Meeting. (general urology). Some industry sponsorship.
Feb 2018
12/4/18 Non-specific interest. No action other than process of open declaration.
Indirect Financial
Course organiser and Chair: North West Basic Science Training Day - course organiser and chair. Some industry sponsorship –
March 2018
12/4/18 Non-specific interest. No action other than process of open declaration.
Alan Chant Committee member none
Jane Collie Committee member Indirect non Financial
Involved in recruitment of patients to the NIHR studies SUSPEND, TISU and PURE.
on application
Specific interest. No action other than process of open declaration.
Direct Non-financial
I am involved in the development of PROMS (patient reported outcome measures) in Cambridge for
on application
Non-specific interest. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 4 of 12
both ureteric stones and renal stones, and have had presentations on the projects at national and international meetings, as well as abstracts published in journals.
Direct
Non-financial
Abstract submitted to World Congress of Endourology – ‘Emergency Extracorporeal Shockwave Lithotripsy (ESWL) for acute ureteric colic: Outcomes from a large UK tertiary centre’.
Nov 2017
1/9/17 Specific interest. No action other than process of open declaration.
Andrew Dickenson
Committee Chair Direct
Non-financial
Chair of British Association of Urological Surgeons (BAUS) Education committee 2015-2017: Committee involved in all aspects of urological education for medical (undergraduate and postgraduate) and allied health care professionals.
18/5/17 Non-specific interest. No action other than process of open declaration.
Direct
Non-financial
Vice chair Surgical Speciality Board for Royal College of Surgeons of Edinburgh (2015-2018) This committee provides advice on all aspects of urology to the Council of the Royal College. I do not have a specific role for advice on Renal and ureteric stones.
18/5/17 Non-specific interest. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 5 of 12
Direct
Financial
Plymouth Urology Private Practice LLP based at Plymouth Nuffield Hospital: Management of private patient with urological diagnoses. Practice reflects NHS practice except vasectomy reversal (not available on NHS). No specific interest of treatment of renal and ureteric stones from April 2017.
18/5/17 April 17 Non-specific interest. No action other than process of open declaration.
Direct
Non-financial
Delegate at BAUS Section of Endourology annual meeting Leeds September 2017. Funded by Plymouth Hospital NHS Trust (PHNT) study leave budget and self-funding. Attendance as part of annual CME requirements
12/10/17 Non-specific interest. No action other than process of open declaration.
Direct
Non-financial
Co-author on poster abstract accepted at EAU Section of Urolithiasis EULIS meeting Vienna. Title: Metabolic joint stone clinic: setting up a new service; Authors: T Dutton, M Moore, A Dickinson, A Connor.
Oct 2017
12/10/17 Non-specific interest. No action other than process of open declaration.
Stephen Griffen
Committee member Direct Non-Financial
Treasurer of the Journal of Paediatric Urology company
on application
Non-specific interest. No action other than process of open declaration.
Direct Financial
Associate editor (Paediatric Urology) British Journal of Urology International Knowledge
on application
Non-specific interest. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 6 of 12
Indirect Financial
Central reader of urodynamics for Pfizer study (A0221047) – a phase 3 trial assessing the efficacy of fesoterodine for treatment of neurogenic detrusor over-activity in children
on application
Non-specific interest. No action other than process of open declaration.
Direct
Non-financial
E-tutor for joint RCS Edinburgh/ university of Edinburgh in urology
18/5/17 Non-specific interest. No action other than process of open declaration.
Direct Financial
Speaker at RSM. ‘Challenges in paediatric urology and nephrology’ and ‘Urinary tract illness in Children’ Travel expenses only.
Feb 2018
15/1/18 Specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Direct Financial
2 private practice paediatric Urology clinics per month and 10-15 private operations per year. Although this could include patients with stones, I have not seen a private patient with stones in 7 years of private practice.
15/1/18
Non- Specific interest. No action other than process of open declaration.
Kathryn Griffin Committee member none
Sally Anne Hulton
Committee member
(stood down 17/1/18)
Direct Financial
Consultation for scientific advice for research trial in Primary Hyperoxaluria paid by Alnylam Pharmaceuticals. Rare renal stone condition - September 2014.
on application
Non-specific interest. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 7 of 12
Indirect Financial
PI for current mRNAi trial for Primary Hyperoxaluria.in children Alnylam and Dicerna pharma. Recruiting for trial
on application
Non-specific interest. No action other than process of open declaration.
Direct Non-financial
Chair of Primary Hyperoxaluria UK Rare Disease group (RADAR)
18/5/17 Non-specific interest. No action other than process of open declaration.
Indirect Financial
Consultancy scientific advice to Dicerna Pharmaceutical regarding development of new SRNAi medication for primary hyperoxaluria. Consultancy fee paid directly to Renal Research Fund a Birmingham Children’s Hospital. No personal financial gain.
1/9/17 Non-specific interest. No action other than process of open declaration.
Direct Non-financial
President-Elect British Association for Paediatric Nephrology (BAPN). Presidency starts June 2018.
12/10/17 Specific interest. Complete exclusion. Stood down from the committee from 17.1.18
Nick Leggett committee member none
Dave Maudgil Committee member Direct
Financial
Private practice includes reporting scans for the following organisations: BMI healthcare, Spire Healthcare, Bridge Clinic Advanced Imaging and Radiology Reporting Online
on application
Specific interest. No action other than process of open declaration as private practice mirrors NHS work.
Direct
Non-financial
Elected to the Communications Committee of the British Society of Interventional Radiology
12/10/17 Non-specific interest. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 8 of 12
Direct non financial appointed regional chair, Royal college of Radiologists
April 2018
16/5/18 Non-specific interest. No action other than process of open declaration.
Shabbir Moochla
Committee member Indirect Financial
Principal investigator for a commercially-funded but investigator-led interventional trial to treat primary hyperoxaluria (Alnylam). Not due to complete during development of guideline.
on application
Non-specific interest. No action other than process of open declaration.
Direct Non-financial
Chair for the Rare Disease group (RADAR) for Adenine phosphoribosyltransferase deficiency (APRTd) hosted by the Renal Association
18/5/17 Non-specific interest. No action other than process of open declaration.
Direct Non-financial
Chair of the Rare Disease Group Hyperoxaluria within the National Registry of Rare Kidney Diseases (RADAR) from Sept 2017
12/10/17 Non-specific interest. No action other than process of open declaration.
Direct Non-financial
Speaker at EULIS (section of Urolithiasis, European Association of Urology conference 6.10.17 on calcium pathophysiology
13/11/17 Non-specific interest. No action other than process of open declaration.
Direct Financial
Private practice (opinion given on 5 patients with stone disease over the last year; no procedures undertaken; no difference to NHS practice where I see >300 patients/year).
12/4/18 Specific interest. No action other than process of open declaration. Private practice in this area is a small proportion of the individual’s overall practice and mirrors their NHS work. Based on the need for the committee member’s expertise and a view that the potential for gain is minimal, in this
Interests Register Renal Stones guideline committee 9 of 12
instance NICE has confirmed that the individual can continue to participate fully.
Direct Non-financial
Abstract on renal stones in thalassaemic patients accepted for UK Kidney Week, Harrogate, Jun 2018
12/4/18 Non-specific interest. No action other than process of open declaration.
Chris Sills Committee member
(stood down March 2018)
none
Kay Thomas Committee Member Indirect Financial
Local principal investigator – TISU trial current (lithotripsy) Recruited patients for NIHR study -TISU
on application
Specific interest. No action other than process of open declaration.
Direct Non-financial
Co-chair Cystinuria Rare Disease Register Group (RaDaR)
18/5/17 Non-specific interest. No action other than process of open declaration.
Direct financial Lecture given on prevention of renal stones to the Royal Society of Medicine Usual expenses for attendance
Oct 2017
12/10/17 Specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Direct
Non-financial
Author of abstracts presented at World Congress of Endourology Canada 2017. Did not personally attend .
Are patient information days useful for patients with Cystinuria? A patients’
12/10/17 Non-specific interest. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 10 of 12
perspective
Protein modelling- A novel approach to risk stratify disease in patients with cystinuria
What Doses Are Our Patients Receiving? An audit examining the radiation dose associated with CT KUB, CT IVU and intra operative fluoroscopy during ureteroscopy and PCNL.
Direct Non-Financial
Abstract marking for European Urology Annual meeting- rare diseases section
13/11/17 Non-specific interest. No action other than process of open declaration.
Direct Non-financial
Attended panel meeting on update of European Guideline Urolithiasis
13/11/17 Specific interest. No action other than process of open declaration.
Direct Non-financial
National Institutes of Health (American) consensus group for cystinuria. Looking at evidence for cystinuria making recommendations for treatment. 2018
12/4/1812 Non-specific interest. No action other than process of open declaration.
Direct Non-financial
European reference network disease coordinator for Rare Renal Stone disease. Coordinating MDTs across Europe on Renal Stones. 2018
12/4/18 Non-specific interest. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 11 of 12
Direct Non-financial
Invited speaker at the Association of Urologists. Topic: Management of complicated stone disease, can we prevent recurrence of Cystinuria stones. Two Cystinuria were presented by group during that meeting. 2018.
12/4/18 Non-specific interest. No action other than process of open declaration.
Direct Non-financial
Abstract reviewer: British Association of Urological Surgeons Limited annual meeting. Topics: 2 Cystinuria papers.
12/4/18 Non-specific interest. No action other than process of open declaration.
Direct
Non-financial
One paper on the Metabolic work up of patients with urolithiasis. This paper presents a diagnostic algorithm with a European urology focus. January 2018.
12/4/18 Specific interest. Partial exclusion in discussion of research recommendation on this topic
Direct
Non-financial
Attended British Assoc of Urological surgeons Annual meeting – Stone disease and endourology
Jan 2018
16/5/18 Specific interest. No action other than process of open declaration.
Direct
Financial
Invited speaker European Reference network Kidney disease group (ERKnet) meeting –medical management of cystinuria. Accommodation and travel expenses.
may 2018
16/5/18 Non-specific interest. Reasonable travel and subsistence expenses only. No action other than process of open declaration.
Interests Register Renal Stones guideline committee 12 of 12
Indirect
Financial
Provided expert opinion on orphan disease-cystinuria. Honorarium for telephone interview paid into research fund
may 2018
16/5/18 Non-specific interest. No action other than process of open declaration.
Direct
Non-financial
AUA presentaions on cystinuria- genotype and 10 year experience
May 2018
16/5/18 Non-specific interest. No action other than process of open declaration.
Direct
Non financial
Educational video for urologists on cystinuria with Boston Scientific. No payment received
may 2018
16/5/18 Non-specific interest. No action other than process of open declaration.
Soha Zouwail Committee member none
Susan Kennedy
Co-optee
attended 1 meeting 15/1/18)
none
